
About Map Chem
Map Chem is a Healthcare company based in Mumbai (India) founded in 2012 by Mithalal Sethia, Ankit Sethia, and Ashish Sethia. Wholesale supplier of pharmaceutical injections, tablets, and medicines in Mumbai. It operates on a B2B model. Its chief executive, as recorded, is Ashish Sethia. Its Indian entity Map Chem Private Limited reported revenue of βΉ40.84 Cr. Map Chem offers products and services including CAVIM 2.5 g, Cepofic 1.5 mg, Albuzest Protine Powder, DULAFUN 100 MG, and Etacept 25 Mg. Its focus areas include Pharmaceuticals, Medicines, Wholesale Distribution and Speciality Drugs. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Map Chem Private Limited is a private limited company based in Mumbai, Maharashtra, India, specializing in wholesale distribution of pharmaceutical products. They supply items such as injections, tablets, anti-cancer medicines, and nutritional supplements to businesses. Operating as a trader and wholesaler, they focus on quality pharmaceutical distribution, including critical care and HIV aids medicines, while ensuring compliance with GST regulations.
- Headquarters Mumbai, India
- Founders Mithalal Sethia, Ankit Sethia, Ashish Sethia
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website mapchem.net
- Legal Name Map Chem Private Limited
- Date of Incorporation 27 Aug, 2004
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹40.84 Cr
FY 2024 · +19% YoY
- Net Profit₹35.8 Lakh
FY 2024 · 1% margin
- EBITDA₹1.60 Cr
FY 2024 · 4% margin
Associated legal entities of Map Chem
Map Chem operates through Map Chem Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Map Chem Private Limited CIN U51496MH2004PTC148271 | Active | 27 Aug 2004 | Mumbai, Maharashtra | ₹40.8 Cr | 2 | View details |
Products & Services of Map Chem
Map Chem offers a comprehensive portfolio of products and services, including CAVIM 2.5 g, Cepofic 1.5 mg, Albuzest Protine Powder, DULAFUN 100 MG, and Etacept 25 Mg.
Injection used for medical treatment purposes.
Injection for therapeutic applications.
Protein powder for health support.
Tablet for medical use.
Injection for specific treatments.
Injection for healthcare needs.
Tablet for cancer-related treatments.
Tablet for medical purposes.
Board of directors of Map Chem Private Limited (Map Chem)
Map Chem Private Limited is the primary company behind Map Chem. The board of Map Chem Private Limited currently have 2 directors; the longest-serving is Ashish Mithalal Sethia, appointed in 2004. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashish Mithalal Sethia DIN 01428188 | Director | 27 Aug 2004 | 22 yrs 2 mo | Map Chem Private Limited |
| Ankit Mithalal Sethia DIN 05326729 | Director | 01 Aug 2012 | 14 yrs 3 mo | Map Chem Private Limited |
People of Map Chem
3 people are tracked at Map Chem (3 in leadership).
| Name | Role | Group |
|---|---|---|
| ex-Co-Founder | Leadership | |
| Co-Founder | Leadership | |
| Co-Founder, CEO | Leadership |
Complete people profiles for Map Chem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Map Chem
Figures of Map Chem Private Limited, the primary company behind Map Chem, for FY 2024. Revenue was ₹40.84 Cr (+19% year on year). Net profit was ₹35.8 Lakh (1% margin). EBITDA was ₹1.60 Cr (4% margin). Revenue has grown at a compounded annual rate of +19% over three years and +15% over five years.
- ₹40.84 CrRevenue · FY 2024 · +19% YoY
- ₹35.8 LakhNet profit · 1% margin
- ₹1.60 CrEBITDA · 4% margin
- ₹5 LakhPaid-up capital
- +19%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Map Chem Private Limited are on its company page.
Detailed financial statements for Map Chem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Map Chem
Map Chem has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Map Chem
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Map Chem
The website of Map Chem (mapchem.net) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 17.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Map Chem
Map Chem was founded in 2012.
Map Chem is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Ashish Sethia is the CEO of Map Chem, as recorded in our data. They have also founded this company.
The primary company behind Map Chem, Map Chem Private Limited, reported revenue of βΉ40.84 Cr for FY 2024, up 19% year on year.
Map Chem Private Limited is a private limited company based in Mumbai, Maharashtra, India, specializing in wholesale distribution of pharmaceutical products. They supply items such as injections, tablets, anti-cancer medicines, and nutritional supplements to businesses. Operating as a trader and wholesaler, they focus on quality pharmaceutical distribution, including critical care and HIV aids medicines, while ensuring compliance with GST regulations.
Map Chem's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Map Chem offers CAVIM 2.5 g, Cepofic 1.5 mg, Albuzest Protine Powder, DULAFUN 100 MG, and 4 more products and services.
Map Chem operates through Map Chem Private Limited.
The legal entities of Map Chem currently have 2 directors, including Ashish Mithalal Sethia, Ankit Mithalal Sethia.